Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused Tricyclic Compounds as novel mTOR inhibitors

Fused Tricyclic Compounds as novel mTOR inhibitors

US Patent 8609675 · Granted Dec 17, 2013

Estimated economic value: $54,459,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of plasma kallikrein and uses thereof2025
Antimalarial agents2025
Polymer linkers and their uses2025
Antimalarial agents2025
Method for manufacturing TFT substrate and TFT substrate thereof2025
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) in2025
Compound for inhibiting PGE2/EP4 signaling transduction inhibiting, preparation 2025
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) in2024
Methods of using substituted pyrazole and pyrazole compounds and for treatment o2024
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcho2024
Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, composi2023
Substituted pyrazole and pyrrole compounds and methods for using them for inhibi2023